CMPS — COMPASS Pathways Share News
0.000.00%
Last trade - 00:00Compass Pathways' depression treatment meets main goal in late‑stage study
U.S. STOCKS ON THE MOVEx-IDEX Corp, Union Pacific, Qualcomm
Compass Pathways falls; fast-track review of depression drug blocked, reports say
Compass Pathways falls; fast-track review of its psychedelic treatment blocked, media reports say
U.S. STOCKS ON THE MOVE-Marriott, Leidos, McDonald's
Compass Pathways to expedite launch of its experimental depression therapy (updated)
U.S. STOCKS ON THE MOVE-Hims & Hers Health, Hertz Global, Metsera
U.S. STOCKS ON THE MOVE-Yum Brands, Waters, Harley-Davidson
Compass Pathways jumps as it speeds up launch plans for depression drug
Biotech firm Compass Pathways' operating income beats Q3 analyst expectations
Compass Pathways to expedite launch timing of its experimental depression therapy
Brief: COMPASS Pathways Q3 EPS USD -1.44
Compass Pathways PLC reports results for the quarter ended June 30 - Earnings Summary
Biotech Compass Pathways Q2 operating income beats analyst expectations
Brief: Compass Pathways Appoints Justin Gover To Board Of Directors
Compass Pathways PLC expected to post a loss of 43 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-DoorDash, Accenture, KB Home
U.S. STOCKS ON THE MOVE-Fiserv, Eli Lilly, Nuclear stocks
Compass Pathways set for worst-day ever after depression drug data disappoints Wall Street